Eisai: Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by European Medicines Agency
TOKYO and CAMBRIDGE, Mass., Ja […]
NEW YORK, NY,October 06, 2022- […]
Continuously expanding the sco […]
HONG KONG, Apr 20, 2022 – […]
Kuala Lumpur, Malaysia / SEAPR […]
SINGAPORE, Mar 12, 2021 – […]
SINGAPORE – Commuters no […]
Billionaire Jack Ma’s An […]
Vancouver, BC, Nov 2, 2020 […]